JPRN-UMIN000009588已完成未知
The effect of combination therapy with Alendronate and Eldecalcitol for glucocorticoid induced osteoporosis -switch from Alfacalcidol to Eldecalcitol- - The effect of combination therapy with Alendronate and Eldecalcitol for glucocorticoid induced osteoporosis -switch from Alfacalcidol to Eldecalcitol
Department of Rheumatic Disease, Shinko Hospital0 个研究点目标入组 60 人开始时间: 2012年12月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with contraindication for Eldecalcitol treatments 2. Patients who are inappropriate for this study by physicians.
研究者
相似试验
已完成
2 期
Assessment of two doses of Alendronate on the treament of osteopenia on menopaused femalesOsteopenia.Menopausal and other perimenopausal disordersIRCT20190325043111N1Esfahan University of Medical Sciences140
尚未招募
不适用
Combination therapy with alendronate and alphacalcidol for prevention of symptomatic vertebral fracture in elderly patients treated with high-dose glucocorticoid: a multicenter open-label randomized controlled trial.glucocorticoid-induced osteoporosisJPRN-UMIN000004217Society for glucocorticoid-induced osteoporosis200
已完成
3 期
Alendronate effects in patients with lumbar spine fractureIRCT20101122005230N3Tabriz University of Medical Sciences60
已完成
不适用
Clinical study on efficacy of alendronate infusion for pediatric osteogenesis imperfecta (including severe form)osteogenesis imperfectaJPRN-UMIN000010615Tohoku University School of Medicine, Department of Pediatrics10
进行中（未招募）
1 期
En randomiseret kontrolleret undersøgelse af alendronat som forebyggende behandling mod udvikling af glucocorticoid induceret osteoporose hos patienter der behandles for malignt lymfom.Age = 18 years. Patients with new diagnosis or recurrence of lymphoma, which is expected to be treated with one of the listed chemotherapy regimens.Expected lifespan =2 yearsMedDRA version: 19.0Level: LLTClassification code 10025315Term: Lymphoma malignantSystem Organ Class: 100000004864EUCTR2015-005688-18-DKDepartment of Hematology, Aalborg University Hospital60